-
1Academic Journal
Authors: V. A. Goryainov, M. M. Kaabak, L. A. Shishlo, N. N. Babenko, M. M. Morozov, В. А. Горяйнов, М. М. Каабак, Л. А. Шишло, Н. Н. Бабенко, М. М. Морозова
Source: Transplantologiya. The Russian Journal of Transplantation; № 1 (2010); 54-57 ; Трансплантология; № 1 (2010); 54-57 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2010-0-1
Subject Terms: миелотоксичность, posttransplantation anemia, erythropoietin, immunosuppression, myelotoxicity, посттрансплантационная анемия, эритропоэтин, иммунодепрессия
File Description: application/pdf
Relation: https://www.jtransplantologiya.ru/jour/article/view/270/333; Vanrenterghem Y., Ponticelly C., Morales J.M. et al. Prevalence and management of anemia in renal transplants recipients: a European survey. Am J Transplant 2003;3:835–45.; Augustine J.J., Hricik D.E. Anemia after kidney transplantation: time for action. J Am Soc Nephrol 2006;17:2962–3.; Bagga A., Hari P., Moudgil A. et al. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephritic syndrome. Am J Kidney Dis 2003;42:1114–20.; Filler G., Gripas R., Mai I et al. Pharmacokinetics of tacrolimus (FK506) in children and adolescents with renal transplants. Nephrol Dial Transplant 1997;12:1668–71.; Gouva C., Nikolopoulos P., Ioanidis J.P. et al. Treating anemia early in renal failure patients slows the decline of renal function; a randomized controlled trial. Kidney Dis 2004;66:753–60.; Kolonko A., Pinoci-Mandok J., Kocierz M. et al. Anemia and erythrocytosis after kidney transplantation: 5-year graft function and survival analysis. Transplant Proc 2009;41(8):3046–51.; Mahmud S.N., Aziz R., Akhtar F. et al. Anemia characteristics after renal transplantation. Transplant Proc 2002;34:24–8.; Moore J., Cockwell P., Little M.A. et al. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Transplantation 2008;86(4):564–70.; Mitsnefes M.M., Subat-Dezulovic M., Khoury P.R. et al. Increasing incidence of post-kidney transplant anemia in children. Am J Transplant 2005;5:1713–8.; Ponticelli C., Villa M. Role of anemia in cardiovascular mortality and morbidity in transplant patients. Nephrol Dial Transplant 2002;17(Suppl 1):41–6.; Rossert J., Fouqueray B., Boffa J.J. Anemia management and the delay of chronic renal failure progression. J Am Soc Nephrol 2003;14:173–7.; Turkowski-Duhem A., Kamar N., Cointault O. et al. Predictive factors of anemia within the first year post renal transplant. Transplantation 2005;7:903–9.; Van Biesen W., Vanholder R., Neys N. et al. Efficacy of erythropoietin administration in the treatment of anemia immediately after renal transplantation. Transplantation 2005;79(3):367–8.; Winkelmayer W.C., Kewalramani R., Rutstein M. et al. Pharmacoepidemiology of anemia in renal transplant recipients. J Am Soc Nephrol 2004;15:1347–52.; Yorgin P.D., Scandling J.D., Belson A. et al. Late post-transplant anemia in adult renal transplant recipients. An underrecognized problem? Am J Transplant 2002;2:429–35.; Al-Uzri A., Yorgin P.D., Kling P.J. Anemia and the effect of immunosuppressive therapy on erythropoiesis. Pediatr Transplant 2003;7:253–64.; Hricik D.E. Anemia after kidney transplantation: Is the incidence increasing? Am J Transplant 2003;3:771–2.; Kamar N., Rostaying L. Negative impact of one-year anemia on long-tern patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycofenolate mofetil. Transplantation 2008;85(8):1120–4.; Ersoy A., Kahvecioglu S., Ersoy C. et al. Anemia due to losartan in hypertensive renal transplant recipients without positive influence on blood pressure. Transplant Proc 2005;37:2148–50.; Kasiske B.L., Vazquez M.A., Harmon W.E. et al. Recommendations for the outpatient surveillance of renal of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11(Suppl 15):1–86.; Kim H.C., Park S.B., Han S.Y. et al. Anemia following renal transplantation. Transplant Proc 2003;35(1):302.; Wilfingseder J., Kainz A., Perco P. et al. Molecular predictors for anemia after kidney transplantation. Nephrol Dial Transplant 2009;24(3):1015–23.; Schwartz G.J., Gautier B.A. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985;106:522–6.; Philipp S., Ollmann H., Schink T. et al. The impact of anemia and kidney function in congestive heart failure and preserved systolic function. Nephrol Dial Transplant 2005;20:915–9.; Shah N., Al-khoury S., Afzali B. et al. Posttransplant anemia in adults renal allograft recipients: prevalence and predictors. Transplantation 2006;81(8):1112–8.; Imoagene-Oyedeji A.E., Rosas S.E., Doyle A.M. et al. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality. J Am Soc Nephrol 2006;17:3240–7.; Thaunat O., Beaumont C., Chatenoud L. et al. Anemia after late introduction of cirolimus may correlate with biochemical levidence of a chronic inflammatory state. Transplantation 2005;80(9):1212–9.; Weiner D.E., Tighiouart H., Vlagopulos P.T. et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 2005;16:1803–10.; Zadrail J., Horak P., Horika V. et al. Endogenous erythropoietin levels and anemia in long-term transplant recipients. Kidney Blood Press. Res 2007;30(30):106–16.; Choukroun G., Deray G., Glotz D. et al. Incidence and management of anemia in renal transplantation : an observational-french study. Nephrol Ther 2008;4(7):575–83.; Chhabra D., Grafals M., Scaro A.I. et al. Impact of anemia after renal transplantation on patients and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol 2008;3:1168–74.; Becker B.N., Becker I.T., Leverson G.E. et al. Erythropoietin therapy may retard progression in chronic renal transplant disfunction. Nephrol Dial Transplant 2002;17:1667–73.; Kahng K., Kang C., Kwak J. Changes in hemoglobin levels after renal transplantation. Transplant Proc 1998;30:3023–4.; Mix T.C., Kazmi W., Khan S. et al. Anemia: A continuing problem following kidney transplantation. Am J Transplant 2003;3:1426–33.; Vanrenterghem I. Anemia after kidney transplantation. Transplantation 2009;87(9):1265–7.; Augustine J.J., Knauss T.C., Schulak J.A. et al. Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients. Am J Transplant 2004;4:2001–6.; Yorgin P.D., Belson A., Sanchez J. et al. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 2002;40:1306–18.; Afzali B., Al-Khoury S., Mikhail A. et al. Anemia after renal transplantation. Am J Kidney Dis 2006;48(4):519–36.; Sistani S., Gruber S., Amm J. et al. Anemia after kidney transplantation (KT): prevalence and risk factors. Transplantation 2004;78(2):287.; Mohanram A., Zhang Z., Shahinfar S. et al. Anemia and end-stage renal disease in patients renal disease in patients with type-2 diabetes and nephropathy. Kidney Int 2004;66:1131–8.; https://www.jtransplantologiya.ru/jour/article/view/270
-
2Academic Journal
Authors: Николаев, Алексей
File Description: text/html
-
3Academic Journal
Source: Клиницист.
Subject Terms: 03 medical and health sciences, 0302 clinical medicine, ТРАНСПЛАНТАЦИЯ ПОЧКИ,ПОСТТРАНСПЛАНТАЦИОННАЯ АНЕМИЯ,ФАКТОРЫ РИСКА,ВЫЖИВАЕМОСТЬ РЕЦИПИЕНТА,ЭПОЭТИН,ИНГИБИТОРЫ АПФ,МИКОФЕНОЛАТА МОФЕТИЛ,РАПАМИЦИН
File Description: text/html
